Atlas Trials

Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

RecordFirmDate
A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07327229)Antengene Biologics Limited2026-02-27
A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001) (NCT06238843)Innovent Biologics (Suzhou) Co. Ltd.2024-06-30

Track Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.